The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

Biologics development and manufacturing: Quality at scale

An overview of our integrated CDMO and CRO capabilities for biologics—from cell line development to commercial manufacturing and tech transfer support.

When choosing the right biologics development and manufacturing partner, the ability to scale with your program is key. At Thermo Fisher Scientific, our end-to-end, integrated CDMO and CRO capabilities for biologics provide support at every stage of the drug development journey—from concept to commercialization—so you can benefit from flexible, tailored support from a single partner. 

This one-team approach helps reduce risk and improve outcomes as you move from phase to phase. And with our global network of sites, you have options no matter where you’re located around the world.
 

This brochure outlines our full suite of services and solutions for biologics development and manufacturing, including cell line development, upstream and downstream process development, analytical and formulation development, process characterization and validation, clinical and commercial manufacturing, and technical transfer support.

It also explores our Path to IND for biologics program, which enables simultaneous IND/IMPD submission and initiation of Phase I clinical trials—with funding included—and delivers a ready-to-use drug product in as few as nine months.

Biologics Development and Manufacturing: Quality at Scale Brochure